Inventor

MORO LUIGI

IT36 patents

⚠️ This page may combine multiple inventors who share the name “MORO LUIGI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MORO LUIGI

COSMO TECHNOLOGIES LTD

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Oral rifamycin SV compositions

Oral rifamycin SV compositions

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Solid composition for the oral administration of dyes and diagnostic use thereof

Solid composition for the oral administration of dyes and diagnostic use thereof

Solid composition for the oral administration of dyes and diagnostic use thereof

Pharmaceutical compositions for the oral administration of heparin or derivatives thereof

CASSIOPEA S P A

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

17alpha, 21-dihydroxypregnene esters as antiandrogenic agents

Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

17 alpha, 21-dihydroxypregnene esters as antiandrogenic agents

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

POLI IND CHIMICA SPA

Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents

Pharmaceutical compositions for transmucosal delivery of peptides

Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products

Muscle relaxant pharmaceutical compositions

ERBA FARMITALIA

Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same

Pharmaceutical sustained-release compositions

Pharmaceutical compositions consisting or consisting essentially of freeze-dried drug-carrying liposomes

AJANI MAURO

17α, 21-dihydroxypregnene esters as antiandrogenic agents

Pharmaceutical compositions for the oral administration of heparin or derivatives thereof

COSMO DERMATOS SRL

17alfa, 21-dihydroxypregnene esters as antiandrogenic agents

MORO LUIGI

Solid composition for the oral administration of dyes and diagnostic use thereof

COSMO TECH LIMITED

Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum